StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a report published on Saturday. The firm issued a hold rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Trading Up 3.5 %
NASDAQ CPIX opened at $1.18 on Friday. The company has a quick ratio of 1.26, a current ratio of 1.44 and a debt-to-equity ratio of 0.62. Cumberland Pharmaceuticals has a 52 week low of $1.07 and a 52 week high of $2.36. The stock has a market capitalization of $16.64 million, a PE ratio of -1.58 and a beta of 0.22. The firm has a 50 day moving average of $1.26 and a two-hundred day moving average of $1.42.
Cumberland Pharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Cumberland Pharmaceuticals
- How to Buy Cheap Stocks Step by Step
- Palantir Cracks $50, Is There Still Time to Get on Board?
- What Are Dividend Achievers? An Introduction
- Insider Buying Signals Upside for These 3 Stocks
- Using the MarketBeat Dividend Tax Calculator
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.